Interesting...., looking through lists of others lucky enough to obtain the orphan grant and many have sponsors ( licensing deals)
Also news to me, it appears that, in previous deals made, big pharma have spent more on these specialised drugs than on greater population peers.
Again, well done PTX on putting the PTX-200 on the radar with the current AML study.
- Forums
- ASX - By Stock
- PTX
- Ann: FDA Grants Orphan Drug Designation for PTX-200 in AML
Ann: FDA Grants Orphan Drug Designation for PTX-200 in AML, page-7
Featured News
Add PTX (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.9¢ |
Change
-0.003(7.14%) |
Mkt cap ! $31.40M |
Open | High | Low | Value | Volume |
4.0¢ | 4.1¢ | 3.9¢ | $75.11K | 1.897M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 355874 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 75 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 355874 | 0.039 |
6 | 700788 | 0.038 |
3 | 80513 | 0.037 |
4 | 399500 | 0.036 |
4 | 298576 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 75 | 1 |
0.041 | 230198 | 2 |
0.042 | 350000 | 2 |
0.043 | 247971 | 2 |
0.044 | 100000 | 1 |
Last trade - 15.59pm 19/06/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online